Yuki Miyamoto

Dr. Yuki Miyamoto

National Research Institute for Child Health and Development
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 April 2018 in Science Advances
Verified
Journal Article
Open access
PDF file
YMYuki Miyamoto
Yuki Miyamoto
TTTomohiro Torii
Tomohiro Torii
Kenji TagoKenji Tago
Kenji Tago
ATAkito Tanoue
Akito Tanoue
STShou Takashima
Shou Takashima
Junji YamauchiJunji Yamauchi
Junji Yamauchi
BIG1 and its effector Arf1 are newly added to the list of signaling molecules controlling axonal myelination.

31 May 2022 in Neurology International
Verified
Journal Article
Open access
PDF file
SNSatoshi Nishino
Satoshi Nishino
YFYoko Fujiki
Yoko Fujiki
TSTakanari Sato
Takanari Sato
YKYukino Kato
Yukino Kato
RSRemina Shirai
Remina Shirai
Junji YamauchiJunji Yamauchi
Junji Yamauchi
Oligodendrocytes (oligodendroglial cells) are glial cells that wrap neuronal axons with their differentiated plasma membranes called myelin membranes. In the pathogenesis of inflammatory cytokine-related oligodendroglial cell and myelin diseases such as multiple sclerosis (MS), typical inflammatory cytokines tumor necrosis factor α (TNFα) and interleukin-6 (IL-6) are thought to contribute to the degeneration and/or progression of the degeneration of oligodendroglial cells and, in turn, the degeneration of naked neuronal cells in the central nervous system (CNS) tissues. Despite the known involvement of these inflammatory cytokines in disease progression, it has remained unclear whether and how TNFα or IL-6 affects the oligodendroglial cells themselves or indirectly. Here we show that TNFα or IL-6 directly inhibits morphological differentiation in FBD-102b cells, which are differentiation models of oligodendroglial cells. Their phenotype changes were supported by the decreased expression levels of oligodendroglial cell differentiation and myelin marker proteins. In addition, TNFα or IL-6 decreased phosphorylation levels of Akt kinase, whose upregulation has been associated with promoting oligodendroglial cell differentiation. Hesperetin, a flavonoid mainly contained in citrus fruit, is known to have neuroprotective effects. Hesperetin might also be able to resolve pre-illness conditions, including the irregulated secretion of cytokines, through diet. Notably, the addition of hesperetin into cells recovered TNFα- or IL-6-induced inhibition of differentiation, as supported by increased levels of marker protein expression and phosphorylation of Akt kinase. These results suggest that TNFα or IL-6 itself contributes to the inhibitory effects on the morphological differentiation of oligodendroglial cells, possibly providing information not only on their underlying pathological effects but also on flavonoids with potential therapeutic effects at the molecular and cellular levels.

1 September 2021 in General Hospital Psychiatry
Verified
Journal Article
Closed access
NKNao Kikkawa
Nao Kikkawa
RSRintaro Sogawa
Rintaro Sogawa
AMAkira Monji
Akira Monji
SSShintaro Sumi
Shintaro Sumi
TMToru Murakawa-Hirachi
Toru Murakawa-Hirachi
CSChisato Shimanoe
Chisato Shimanoe

15 April 2021 in Molecular Biology of the Cell
Verified
Journal Article
Open access
YMYuki Miyamoto
Yuki Miyamoto
TTTomohiro Torii
Tomohiro Torii
MTMiho Terao
Miho Terao
STShuji Takada
Shuji Takada
ATAkito Tanoue
Akito Tanoue
Junji YamauchiJunji Yamauchi
Junji Yamauchi
The unique biphasic role of Rnd2, an atypical branch of the Rho family GTPases, in oligodendrocyte myelination is described. Rnd2 positively regulates myelination in the early myelinating period and negatively regulates it in the subsequent period, by changes of the Rho-kinase activities, a common downstream molecule of Rho GTPases.

16 April 2020 in Biomedicines
Verified
Journal Article
Open access
PDF file
NMNaoto Matsumoto
Naoto Matsumoto
YMYuki Miyamoto
Yuki Miyamoto
KHKohei Hattori
Kohei Hattori
AIAkihiro Ito
Akihiro Ito
HHHironori Harada
Hironori Harada
Junji YamauchiJunji Yamauchi
Junji Yamauchi
Myelin sheaths created by oligodendroglial cells encase neuronal axons to achieve saltatory conduction and protect axons. Pelizaeus-Merzbacher disease (PMD) is a prototypic, hereditary demyelinating oligodendroglial disease of the central nervous system (CNS), and is currently known as hypomyelinating leukodystrophy 1 (HLD1). HLD12 is an autosomal recessive disorder responsible for the gene that encodes vacuolar protein sorting-associated protein 11 homolog (VPS11). VPS11 is a member of the molecular group controlling the early endosome antigen 1 (EEA1)- and Rab7-positive vesicle-mediated protein trafficking to the lysosomal compartments. Herein, we show that the HLD12-associated Cys846-to-Gly (C846G) mutation of VPS11 leads to its aggregate formation with downregulated signaling through 70 kDa S6 protein kinase (p70S6K) in the oligodendroglial cell line FBD-102b as the model. In contrast, wild-type proteins are localized in both EEA1- and Rab7-positive vesicles. Cells harboring the C846G mutant constructs decrease differentiated phenotypes with web-like structures following differentiation, whereas parental cells exhibit them suitably. It is of note that we identify PP1C and PP2A as the protein phosphatases for phosphorylated Thr-389 of p70S6K essential for kinase activation in cells. The respective knockdown experiments or inhibitor treatment stimulates phosphorylation of p70S6K and ameliorates the inhibition of morphological differentiation, as well as the formation of protein aggregates. These results indicate that inhibition of p70S6K phosphatases PP1C and PP2A improves the defective morphological differentiation associated with HLD12 mutation, thereby hinting at amelioration based on a possible molecular and cellular pathological mechanism underlying HLD12.

22 December 2021 in Neurology International
Verified
Journal Article
Open access
PDF file
SSSui Sawaguchi
Sui Sawaguchi
Kenji TagoKenji Tago
Kenji Tago
HOHiroaki Oizumi
Hiroaki Oizumi
KOKatsuya Ohbuchi
Katsuya Ohbuchi
MYMasahiro Yamamoto
Masahiro Yamamoto
Junji YamauchiJunji Yamauchi
Junji Yamauchi
Hypomyelinating leukodystrophy 7 (HLD7) is an autosomal recessive oligodendroglial cell-related myelin disease, which is associated with some nucleotide mutations of the RNA polymerase 3 subunit a (polr3a) gene. POLR3A is composed of the catalytic core of RNA polymerase III synthesizing non-coding RNAs, such as rRNA and tRNA. Here, we show that an HLD7-associated nonsense mutation of Arg140-to-Ter (R140X) primarily localizes POLR3A proteins as protein aggregates into lysosomes in mouse oligodendroglial FBD−102b cells, whereas the wild type proteins are not localized in lysosomes. Expression of the R140X mutant proteins, but not the wild type proteins, in cells decreased signaling through the mechanistic target of rapamycin (mTOR), controlling signal transduction around lysosomes. While cells harboring the wild type constructs exhibited phenotypes with widespread membranes with myelin marker protein expression following the induction of differentiation, cells harboring the R140X mutant constructs did not exhibit them. Ibuprofen, a non-steroidal anti-inflammatory drug (NSAID), which is also known as an mTOR signaling activator, ameliorated defects in differentiation with myelin marker protein expression and the related signaling in cells harboring the R140X mutant constructs. Collectively, HLD7-associated POLR3A mutant proteins are localized in lysosomes where they decrease mTOR signaling, inhibiting cell morphological differentiation. Importantly, ibuprofen reverses undifferentiated phenotypes. These findings may reveal some of the pathological mechanisms underlying HLD7 and their amelioration at the molecular and cellular levels.